Chemoinformaics analysis of 4-methylpentyl ester
| Molecular Weight | 545.629 | nRot | 9 |
| Heavy Atom Molecular Weight | 506.317 | nRig | 26 |
| Exact Molecular Weight | 545.263 | nRing | 5 |
| Solubility: LogS | -4.65 | nHRing | 3 |
| Solubility: LogP | 2.638 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 39 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 10 | APOL | 82.7529 |
| nHD | 2 | BPOL | 51.2511 |
| QED | 0.448 |
| Synth | 4.98 |
| Natural Product Likeliness | 2.02 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.997 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.919 |
| MDCK | 0.0000372 |
| BBB | 0.629 |
| PPB | 0.479135 |
| VDSS | 1.42 |
| FU | 0.424973 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.675 |
| CYP2c19-inh | 0.109 |
| CYP2c19-sub | 0.899 |
| CYP2c9-inh | 0.249 |
| CYP2c9-sub | 0.321 |
| CYP2d6-inh | 0.816 |
| CYP2d6-sub | 0.262 |
| CYP3a4-inh | 0.946 |
| CYP3a4-sub | 0.921 |
| CL | 9.586 |
| T12 | 0.1 |
| hERG | 0.083 |
| Ames | 0.019 |
| ROA | 0.119 |
| SkinSen | 0.024 |
| Carcinogencity | 0.741 |
| EI | 0.006 |
| Respiratory | 0.075 |
| NR-Aromatase | 0.195 |
| Antiviral | Yes |
| Prediction | 0.831526 |